Literature DB >> 11325820

Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL).

R Varon1, A Reis, G Henze, H G von Einsiedel, K Sperling, K Seeger.   

Abstract

The Nijmegen Breakage Syndrome (NBS) is a rare autosomal recessive disorder associated with immune deficiency, chromosome fragility, and increased susceptibility to lymphoid malignancies. The aim of the present study was to elucidate the potential role of the gene mutated in NBS (NBS1) in the pathogenesis and disease progression of childhood acute lymphoblastic leukemia (ALL). Samples from 47 children with first relapse of ALL were analyzed for mutations in all 16 exons of the NBS1 gene, and in 7 of them (14.9%), four novel amino acid substitutions were identified. Mutations S93L, D95N, and I171V occur in the two known domains of nibrin that are probably involved in protein-protein interactions. Germ-line origin of the I171V mutation was confirmed in three patients, whereas the D95N exchange was present only in leukemic cells. The R215W mutation was observed in one ALL but also in a population-based study and probably represents a rare sequence variant. No additional mutations were found on the second allele in any of these seven patients. The observed NBS1 gene mutations in ALL patients points to its possible involvement in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325820

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  High prevalence of the NBN gene mutation c.657-661del5 in Southeast Germany.

Authors:  M H Maurer; K Hoffmann; K Sperling; R Varon
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

Review 2.  Next-generation sequencing for inherited breast cancer risk: counseling through the complexity.

Authors:  Irene R Rainville; Huma Q Rana
Journal:  Curr Oncol Rep       Date:  2014-03       Impact factor: 5.075

3.  Heterozygous p.I171V mutation of the NBN gene as a risk factor for lung cancer development.

Authors:  Ewelina Maria Kałużna; Jolanta Rembowska; Iwona Ziółkowska-Suchanek; Bogna Świątek-Kościelna; Piotr Gabryel; Wojciech Dyszkiewicz; Jerzy Stanisław Nowak
Journal:  Oncol Lett       Date:  2015-09-17       Impact factor: 2.967

4.  Tracking of specific integrant clones in dogs treated with foamy virus vectors.

Authors:  Ken Ohmine; Yi Li; Thomas R Bauer; Dennis D Hickstein; David W Russell
Journal:  Hum Gene Ther       Date:  2010-12-19       Impact factor: 5.695

5.  First case of aplastic anemia in a Japanese child with a homozygous missense mutation in the NBS1 gene (I171V) associated with genomic instability.

Authors:  Hiroyuki Shimada; Kimiko Shimizu; Sachiyo Mimaki; Tokuki Sakiyama; Tetsuya Mori; Noriko Shimasaki; Jun Yokota; Kei Nakachi; Tsutomu Ohta; Misao Ohki
Journal:  Hum Genet       Date:  2004-08-24       Impact factor: 4.132

6.  Structure of a second BRCT domain identified in the nijmegen breakage syndrome protein Nbs1 and its function in an MDC1-dependent localization of Nbs1 to DNA damage sites.

Authors:  Chao Xu; Liming Wu; Gaofeng Cui; Maria Victoria Botuyan; Junjie Chen; Georges Mer
Journal:  J Mol Biol       Date:  2008-06-14       Impact factor: 5.469

7.  Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes.

Authors:  Terry J Gaymes; Sydney Shall; Lee J MacPherson; Natalie A Twine; Nicholas C Lea; Farzin Farzaneh; Ghulam J Mufti
Journal:  Haematologica       Date:  2009-05       Impact factor: 9.941

8.  NBS1 Heterozygosity and Cancer Risk.

Authors:  Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2008-06       Impact factor: 2.236

9.  Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma.

Authors:  Johanna M Schuetz; Amy C MaCarthur; Stephen Leach; Agnes S Lai; Richard P Gallagher; Joseph M Connors; Randy D Gascoyne; John J Spinelli; Angela R Brooks-Wilson
Journal:  BMC Med Genet       Date:  2009-11-16       Impact factor: 2.103

10.  Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.

Authors:  Sylvie Desjardins; Joly Charles Beauparlant; Yvan Labrie; Geneviève Ouellette; Francine Durocher
Journal:  BMC Cancer       Date:  2009-06-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.